Status
Conditions
About
This is a retrospective clinical study to analyze the clinical characteristics, complications, and effects of different treatment options on long-term prognosis of severe tuberculosis patients. All cases of severe tuberculosis diagnosed between 2016 and 2021 were included in the electronic medical record system of one center, and data such as demographics, hospitalization information, clinical information, laboratory or imaging examinations, treatment plans, and outcomes were collected.
Enrollment
Sex
Volunteers
Inclusion criteria
For patients with severe pulmonary tuberculosis, imaging and grading diagnosis meet any of the following:
Damaged lung ≥ 1 lobe
Chest CT shows lesions in ≥3 lung lobes
Hematogenous disseminated pulmonary tuberculosis
caseous pneumonia
bronchial tuberculosis
Multiple hilar or mediastinal lymph node enlargement in primary pulmonary tuberculosis
Rifampicin-resistant, multidrug-resistant, polydrug-resistant or pan-drug-resistant tuberculosis
Combined more than 2 cavities over 8mm
Tuberculous massive hemoptysis
Pulmonary tuberculosis complicated with acute infection (including multidrug-resistant bacterial infection, fungal infection or multiple infection)
Combined with extrapulmonary tuberculosis
Intracranial tuberculosis, spinal cord and/or meningeal tuberculosis
Pleural effusion, pericardial effusion
Multiple sites of lymphatic tuberculosis or surgery is necessary
Abdominal tuberculosis, tuberculous peritonitis (ascites or multiple serous cavities)
Musculoskeletal tuberculosis
Urinary or renal tuberculosis
Adrenal tuberculosis in hypoadrenal insufficiency
Liver tuberculosis
Age and gender are not limited.
Exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal